電気生理学市場 – 2030年までの世界予測

本レポートは、電気生理学市場を分析し、機器・消耗品、がんの種類、手技、エンドユーザー、地域といった様々なセグメントに基づいて、市場規模と将来の成長ポテンシャルを推定することを目的としています。また、主要企業の競合分析に加え、企業概要、サービス内容、最近の動向、主要な市場戦略についても解説しています。

本レポートは、包括的なデータの徹底的な分析を通じて、電気生理学市場における市場リーダー、新規参入企業、そして中小企業の投資評価を支援し、堅固なリスク評価と十分な情報に基づいた投資判断を可能にします。アプリケーション、エンドユーザー、地域といった側面を網羅した綿密な市場セグメンテーションにより、的確なセグメントターゲティングのための的確な洞察が得られます。また、重要なトレンド、成長要因、課題、そして将来展望を網羅的に評価し、的確な判断に基づいた戦略的意思決定を支援します。

世界の電気生理学市場は、2025年の125億5,000万米ドルから2030年には217億2,000万米ドルに達し、予測期間中に年平均成長率（CAGR）11.6%で成長すると予測されています。電気生理学市場の予測成長は、技術の進歩と研究資金の増加によって牽引されています。世界的な価値に基づくケアと早期介入へのシフトは、植込み型ループレコーダーやウェアラブル心電図デバイスなどの診断用EPツールの普及を促進しています。さらに、COVID-19後の遠隔医療の成長は、遠隔不整脈モニタリングとフォローアップケアへのアクセスを改善しました。心臓プログラムへの政府投資の増加、官民パートナーシップからの投資の増加、そしてAIとロボットナビゲーションシステムの継続的な統合は、手順の効率性と標準化をさらに向上させます。全体として、これらの要因が電気生理学市場の世界的な力強い拡大を促進しています。

The global electrophysiology market is expected to reach USD 21.72 billion by 2030 from USD 12.55 billion in 2025, at a CAGR of 11.6% during the forecast period. The projected growth in the electrophysiology market is driven by technological advancements and increased research funding. The worldwide shift toward value-based care and early intervention also encourages wider adoption of diagnostic EP tools like implantable loop recorders and wearable ECG devices. Additionally, the growth of telehealth after COVID-19 has improved access to remote arrhythmia monitoring and follow-up care. Increased government investment in cardiac programs, rising investments from public-private partnerships, and ongoing integration of AI and robotic navigation systems further improve procedure efficiency and standardization. Overall, these factors are fueling strong global expansion of the electrophysiology market.

“On the basis of product, the electrophysiology ablation catheters commanded the largest share in the electrophysiology market in 2024.”

The electrophysiology market is categorized into several segments: electrophysiology laboratory devices, electrophysiology ablation catheters, electrophysiology diagnostic catheters, EP access products, and additional device types. The expansion of the electrophysiology (EP) ablation catheter sector is propelled by multiple factors. Notably, there is an increasing global incidence of atrial fibrillation (AF) and other cardiac arrhythmias, particularly within aging demographics, which heightens the demand for effective therapeutic interventions. Additionally, innovations in catheter technologies—such as contact force sensing, irrigated-tip designs, and pulsed field ablation—are enhancing safety, accuracy, and efficacy, thereby facilitating increased adoption among electrophysiologists.

“On the basis of indication, the atrial fibrillation devices segment held the largest share in the electrophysiology market in 2024.”

By product, the electrophysiology market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white (WPW) syndrome, and other indications. The expansion of the atrial fibrillation (AF) segment within the electrophysiology (EP) market is largely attributed to a convergence of demographic, lifestyle, clinical, and technological influences. The increasing global demographic of aging individuals, alongside rising rates of obesity, hypertension, diabetes, and sedentary behaviors, has led to a notable surge in AF prevalence. This growing burden of AF is driving heightened demand for EP diagnostics and therapeutic interventions. Moreover, significant advancements in EP procedural techniques, such as enhanced catheter ablation methods, state-of-the-art mapping systems, and sophisticated intracardiac imaging technologies, have markedly improved both the efficacy and safety profiles of interventions. These innovations are prompting clinicians to adopt ablation procedures earlier in the treatment continuum and with greater frequency, reflecting a paradigm shift in the management of AF.

“By region, North America accounted for the largest market share in 2024.”

The electrophysiology sector in North America is experiencing robust expansion, primarily driven by the rising incidence of cardiac arrhythmias, notably atrial fibrillation. This trend correlates with an aging demographic and a high prevalence of comorbidities such as obesity, diabetes, and hypertension. Consequently, there is an escalating demand for advanced diagnostic and therapeutic electrophysiological procedures. Recent innovations—including 3D electro-anatomical mapping, enhanced radiofrequency and cryoablation technologies, and the introduction of pulsed-field ablation—have markedly improved procedural accuracy, patient safety, and clinical outcomes. These advancements are facilitating greater integration of electrophysiology practices within standard cardiology workflows.

“Asia Pacific to register the highest CAGR during the forecast period.”

During the forecast period, the Asia Pacific (APAC) region is poised to experience considerable growth in the electrophysiology market. This region encompasses key markets such as India, China, Japan, Australia, South Korea, and Rest of Asia Pacific. The APAC electrophysiology market is witnessing a notable acceleration due to several interrelated factors. The escalating healthcare costs in major APAC countries—including China, India, Japan, and South Korea—are driving healthcare providers to adopt advanced medical technologies at an expedited pace. Enhanced healthcare infrastructure is facilitating this transition, allowing for greater accessibility to sophisticated electrophysiological devices. Moreover, the rising prevalence of cardiovascular diseases, attributable to demographic shifts such as aging populations, urbanization, and changing lifestyles, underscores the urgent need for effective diagnosis and treatment methodologies. Electrophysiology procedures, significantly relied upon for assessing and managing cardiac disorders, are consequently fueling demand for associated diagnostic and therapeutic devices within the region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
• By Designation: C-level–27%, Director-level–18%, and Others–55%
• By Region: North America–50%, Europe–20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5%

Key players in the electrophysiology market are Johnson & Johnson Services, Inc.(US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Boston Scientific Corporation (US), Japan Lifeline Co., Ltd (Japan), Stereotaxis, Inc.(US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), Teleflex Incorporated (US), Acutus Medical, Inc. (US), Merit Medical Systems (US), OSYPKA MEDICAL (Germany), Cook (US), Epmap-System (Germany), CathRx Ltd. (Australia), EP Solutions (Switzerland), CathVision (Denmark), TZ Medical, Inc. (US), APN Health, LLC (US), Lepu Medical Technology(Beijing)Co., Ltd (China), CardioFocus (US), Schwarzer Cardiotek (Germany), and Imricor (US).

Study Coverage:

The report analyzes the electrophysiology market and aims at estimating the market size and future growth potential of this market based on various segments such as devices & consumables, cancer type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Electrophysiology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers

• The report studies the electrophysiology market based on product, indication, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets concerning their growth trends, prospects, and contributions to the global electrophysiology market.
• The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Electrophysiology market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

• Analysis of key drivers (technological innovations for advanced, effective, and easy-to-use electrophysiological devices; high geriatric population and increased prevalence of cardiovascular diseases; rising investments, funds, and grants for cardiac surgeries and electrophysiology; increasing cardiovascular disease incidence and procedural volume), restraints (high product cost and inadequate reimbursement in developing and under-resourced healthcare settings, unfavorable healthcare reforms in US); opportunities (substantial growth opportunities in emerging economies, popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services), and challenges (global shortage of skilled and experienced personnel) influencing the growth of the electrophysiology market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the electrophysiology market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the Electrophysiology market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electrophysiology market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Johnson & Johnson Services, Inc. (US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), and Boston Scientific Corporation (US), among others.

Table of Contents

1               INTRODUCTION              30

1.1           STUDY OBJECTIVES       30

1.2           MARKET DEFINITION   30

1.3           STUDY SCOPE   31

1.3.1        MARKET SEGMENTATION & REGIONAL SCOPE 31

1.3.2        INCLUSIONS & EXCLUSIONS       32

1.3.3        YEARS CONSIDERED      33

1.3.4        CURRENCY CONSIDERED            33

1.4           STAKEHOLDERS               33

1.5           SUMMARY OF CHANGES               34

2               RESEARCH METHODOLOGY       35

2.1           RESEARCH APPROACH  35

2.1.1        SECONDARY DATA          35

2.1.1.1    Key secondary sources         36

2.1.1.2    Key data from secondary sources       36

2.1.2        PRIMARY DATA 37

2.1.2.1    Key primary sources             37

2.1.2.2    Objectives of primary research           37

2.1.2.3    Key data from primary sources           38

2.1.2.4    Breakdown of primaries      38

2.1.2.5    Key insights from primaries                39

2.2           MARKET SIZE ESTIMATION         40

2.2.1        REVENUE SHARE ANALYSIS         40

2.2.2        BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)                 42

2.2.3        TOP-DOWN APPROACH (UTILIZATION RATE AND ADOPTION PATTERN)  42

2.2.4        COMPANY PRESENTATIONS & PRIMARY INTERVIEWS                 43

2.3           GROWTH FORECAST      44

2.4           DATA TRIANGULATION                46

2.5           STUDY ASSUMPTIONS  47

2.6           RESEARCH IMITATIONS                47

2.6.1        SCOPE-RELATED LIMITATIONS                 47

2.6.2        METHODOLOGY-RELATED LIMITATIONS           47

2.7           RISK ANALYSIS  48

3               EXECUTIVE SUMMARY  49

4               PREMIUM INSIGHTS       52

4.1           ELECTROPHYSIOLOGY MARKET OVERVIEW       52

4.2           NORTH AMERICA: ELECTROPHYSIOLOGY MARKET,  BY PRODUCT AND COUNTRY    53

4.3           ELECTROPHYSIOLOGY MARKET: REGIONAL MIX                 53

4.4           ELECTROPHYSIOLOGY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES         54

4.5           ELECTROPHYSIOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS 54

5               MARKET OVERVIEW       55

5.1           INTRODUCTION              55

5.2           MARKET DYNAMICS       55

5.2.1        DRIVERS               56

5.2.1.1    Technological innovations for advanced, effective, and easy-to-use electrophysiological devices         56

5.2.1.1.1 Rising use of non-invasive cardiac mapping    56

5.2.1.1.2 Increasing use of improved intracardiac ablation systems                 57

5.2.1.1.3 Rising use of MRI-guided ablation procedures                57

5.2.1.1.4 Increasing ultrasound guidance in electrophysiology labs                 58

5.2.1.2    High geriatric population and increased prevalence of cardiovascular diseases        58

5.2.1.3    Rising investments, funds, and grants for cardiac surgeries and electrophysiology  59

5.2.1.4    Increasing cardiovascular disease incidence and procedural volume   60

5.2.2        RESTRAINTS      61

5.2.2.1    High product cost and inadequate reimbursement in developing and under-resourced healthcare settings          61

5.2.2.2    Unfavorable healthcare reforms in US              62

5.2.3        OPPORTUNITIES              63

5.2.3.1    Substantial growth opportunities in emerging economies                 63

5.2.3.2    Popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services                64

5.2.4        CHALLENGES    64

5.2.4.1    Global shortage of skilled and experienced personnel    64

5.3           INDUSTRY TRENDS         65

5.3.1        INTEGRATION OF DIGITAL TECHNOLOGIES, ARTIFICAL INTELLIGENCE, AND REMOTE MONITORING IN ELECTROPHYSIOLOGY 65

5.3.2        ROBOTIC-ASSISTED ABLATION AND NAVIGATION TECHNOLOGIES FOR BETTER TRACTION IN ELECTROPHYSIOLOGY 65

5.4           TECHNOLOGY ANALYSIS             66

5.4.1        KEY TECHNOLOGIES     66

5.4.1.1    3D mapping and navigation systems 66

5.4.1.2    Cryoablation and radiofrequency ablation technologies 67

5.4.2        COMPLEMENTARY TECHNOLOGIES       67

5.4.2.1    Cardiac imaging technologies             67

5.4.2.2    Robotic navigation systems 67

5.4.3        ADJACENT TECHNOLOGIES       68

5.4.3.1    AI-enabled intravascular optical coherence tomography (OCT)                 68

5.4.3.2    AI-driven view guidance in intra-cardiac echocardiography (ICE)                 68

5.5           PORTER’S FIVE FORCES ANALYSIS           68

5.5.1        INTENSITY OF COMPETITIVE RIVALRY 69

5.5.2        BARGAINING POWER OF BUYERS             70

5.5.3        BARGAINING POWER OF SUPPLIERS       70

5.5.4        THREAT OF SUBSTITUTES          70

5.5.5        THREAT OF NEW ENTRANTS      70

5.6           KEY STAKEHOLDERS & BUYING CRITERIA            71

5.6.1        KEY STAKEHOLDERS IN BUYING PROCESS           71

5.6.2        KEY BUYING CRITERIA  72

5.7           REGULATORY ANALYSIS               72

5.7.1        REGULATORY FRAMEWORK       72

5.7.1.1    North America      73

5.7.1.1.1 US           73

5.7.1.1.2 Canada   74

5.7.1.2    Europe   74

5.7.1.3    Asia Pacific            75

5.7.1.3.1 Japan      75

5.7.1.3.2 China      76

5.7.1.3.3 India       76

5.7.1.4    Latin America       77

5.7.1.4.1 Brazil      77

5.7.1.5    Middle East & Africa            77

5.7.1.5.1 UAE        77

5.7.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             78

5.8           REIMBURSEMENT SCENARIO ANALYSIS                 79

5.9           PATENT ANALYSIS          81

5.9.1        PATENT PUBLICATION TRENDS FOR ELECTROPHYSIOLOGY MARKET               81

5.9.2        LIST OF KEY PATENTS   83

5.10         TRADE ANALYSIS             84

5.10.1      IMPORT DATA FOR HS CODE 901890, 2020−2024                 84

5.10.2      EXPORT DATA FOR HS CODE 901890, 2020−2024                 85

5.11         PRICING ANALYSIS          85

5.11.1      INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022–2024                 85

5.11.2      AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022–2024                 86

5.12         KEY CONFERENCES & EVENTS, 2025−2026            87

5.13         UNMET NEEDS & END-USER EXPECTATIONS     88

5.14         VALUE CHAIN ANALYSIS               88

5.15         SUPPLY CHAIN ANALYSIS             90

5.16         ECOSYSTEM ANALYSIS  91

5.17         CASE STUDY ANALYSIS 92

5.17.1      JOHNSON & JOHNSON TO EXPAND CARTO SUITE AND LEVERAGE AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING              92

5.17.2      ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY          92

5.17.3      PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT            93

5.18         ADJACENT MARKET ANALYSIS  94

5.19         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       94

5.20         INVESTMENT & FUNDING SCENARIO     94

5.21         IMPACT OF AI/GEN AI ON ELECTROPHYSIOLOGY MARKET               95

5.22         IMPACT OF 2025 US TARIFF ON ELECTROPHYSIOLOGY MARKET               95

5.22.1      KEY TARIFF RATES          96

5.22.2      PRICE IMPACT ANALYSIS             97

5.22.3      IMPACT ON COUNTRY/REGION                97

5.22.3.1  North America      97

5.22.3.1.1                US           97

5.22.3.2  Europe   98

5.22.3.3  Asia Pacific            98

5.22.4      IMPACT ON END-USE INDUSTRIES          99

5.22.4.1  Hospitals & clinics                99

5.22.4.2  Ambulatory surgery centers                99

6               ELECTROPHYSIOLOGY MARKET, BY PRODUCT 100

6.1           INTRODUCTION              101

6.2           ELECTROPHYSIOLOGY LABORATORY DEVICES 102

6.2.1        3D MAPPING SYSTEMS  103

6.2.1.1    Development of alternative technologies to limit market growth                 103

6.2.2        ELECTROPHYSIOLOGY RECORDING SYSTEMS   105

6.2.2.1    Increasing public-private funding for developing advanced novel recording systems to augment market growth 105

6.2.3        RADIOFREQUENCY (RF) ABLATION SYSTEMS    106

6.2.3.1    Cost-effectiveness and technological advancements to spur segment growth    106

6.2.4        INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS           108

6.2.4.1    Rising lifestyle- and age-related disorders to drive adoption for cardiac disease treatment    108

6.2.5        ELECTROPHYSIOLOGY X-RAY SYSTEMS                109

6.2.5.1    High incidence of cardiovascular disorders and availability of technologically advanced equipment to boost market growth       109

6.2.6        REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS              111

6.2.6.1    Favorable reimbursement scenario to propel market growth                 111

6.3           ELECTROPHYSIOLOGY ABLATION CATHETERS                 113

6.3.1        CRYOABLATION CATHETERS     114

6.3.1.1    Therapeutic advantages and better clinical studies to drive market growth       114

6.3.2        RADIOFREQUENCY (RF) ABLATION CATHETERS                 116

6.3.2.1    Technologically-advanced and safer catheters to drive adoption among healthcare professionals         116

6.3.3        MICROWAVE ABLATION (MWA) CATHETERS      118

6.3.3.1    Smaller diameter antennas, faster procedure times, and larger heating zones to aid market growth   118

6.3.4        LASER ABLATION CATHETERS  119

6.3.4.1    Launch of technologically-advanced laser ablation catheters to drive adoption in healthcare settings 119

6.4           ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS                 121

6.4.1        CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS       122

6.4.1.1    Development of technologically-advanced fixed and steerable diagnostic catheters to favor market growth    122

6.4.2        ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS       124

6.4.2.1    Advanced electrophysiology diagnostic catheters to improve patient outcomes and optimize surgical procedures       124

6.4.3        ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS       125

6.4.3.1    Availability of advanced ultrasound catheters and focus on supportive regulatory frameworks to drive segment       125

6.5           ELECTROPHYSIOLOGY ACCESS DEVICES             126

6.5.1        LAUNCH OF ADVANCED ACCESS DEVICES TO ENHANCE EFFICIENCY DURING ABLATION CATHETER MAPPING AND POSITIONING   126

6.6           OTHER ELECTROPHYSIOLOGY PRODUCTS         128

7               ELECTROPHYSIOLOGY MARKET, BY INDICATION                 129

7.1           INTRODUCTION              130

7.2           ATRIAL FIBRILLATION  130

7.2.1        DEVELOPMENT OF ADVANCED CARDIAC MAPPING SYSTEMS FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET                 130

7.3           ATRIAL FLUTTER             132

7.3.1        HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATING ATRIAL FLUTTER TO PROPEL MARKET GROWTH          132

7.4           ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)               134

7.4.1        INCREASING EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR TREATMENT OF AVNRT TO AID MARKET GROWTH             134

7.5           WOLFF-PARKINSON-WHITE (WPW) SYNDROME                 135

7.5.1        PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO AUGMENT MARKET GROWTH        135

7.6           OTHER INDICATIONS   137

8               ELECTROPHYSIOLOGY MARKET, BY END USER 139

8.1           INTRODUCTION              140

8.2           HOSPITALS & CARDIAC CENTERS             140

8.2.1        PRESENCE OF BETTER CATHETERIZATION AND ELECTROPHYSIOLOGY LABORATORIES IN HOSPITALS TO SUPPORT MARKET GROWTH     140

8.3           AMBULATORY SURGERY CENTERS          141

8.3.1        DEMAND FOR MINIMAL HOSPITAL STAYS AND HIGH INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH             141

8.4           OTHER END USERS         143

9               ELECTROPHYSIOLOGY MARKET, BY REGION     145

9.1           INTRODUCTION              146

9.2           NORTH AMERICA             147

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 148

9.2.2        US           152

9.2.2.1    US to dominate North American electrophysiology market during forecast period      152

9.2.3        CANADA               156

9.2.3.1    Growing government research funding to support market growth                 156

9.3           EUROPE               160

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      160

9.3.2        GERMANY           164

9.3.2.1    Rising prevalence of atrial fibrillation and associated arrhythmias to propel market growth      164

9.3.3        UK          168

9.3.3.1    High geriatric population and rise in cardiac diseases to fuel market growth       168

9.3.4        FRANCE                172

9.3.4.1    Favorable government healthcare policies and schemes to support market growth        172

9.3.5        ITALY    176

9.3.5.1    Rising incidence of cardiovascular diseases to drive adoption of electrophysiology devices    176

9.3.6        SPAIN    179

9.3.6.1    Rising number of cardiac ablation procedures to drive  adoption of electrophysoiology products           179

9.3.7        REST OF EUROPE             182

9.4           ASIA PACIFIC     186

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 186

9.4.2        JAPAN   191

9.4.2.1    Favorable reimbursement scenario and presence of universal healthcare policies to boost market growth      191

9.4.3        CHINA  195

9.4.3.1    Growing geriatric population and rising prevalence of cardiovascular diseases to favor market growth               195

9.4.4        INDIA    199

9.4.4.1    Favorable government healthcare initiatives to support market growth    199

9.4.5        AUSTRALIA         202

9.4.5.1    Increasing target disease burden and rising government funding to spur market growth          202

9.4.6        SOUTH KOREA  205

9.4.6.1    Supportive government initiatives to drive market         205

9.4.7        REST OF ASIA PACIFIC   209

9.5           LATIN AMERICA                212

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 212

9.5.2        BRAZIL 216

9.5.2.1    Modernization of healthcare facilities to propel market growth                 216

9.5.3        MEXICO                220

9.5.3.1    Favorable investment scenario for medical device manufacturers to fuel market growth           220

9.5.4        REST OF LATIN AMERICA             223

9.6           MIDDLE EAST & AFRICA                226

9.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 227

9.6.2        GCC COUNTRIES              231

9.6.2.1    Kingdom of Saudi Arabia    235

9.6.2.1.1 Rising number of private hospitals and increasing government financial support to fuel market growth            235

9.6.2.2    UAE        239

9.6.2.2.1 High clinical demand, increased government investment, and technological progress to aid market growth    239

9.6.2.3    Rest of GCC Countries        242

9.6.3        REST OF MIDDLE EAST & AFRICA             245

10            COMPETITIVE LANDSCAPE         249

10.1         INTRODUCTION              249

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            249

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ELECTROPHYSIOLOGY MARKET               249

10.3         REVENUE ANALYSIS, 2020–2024  251

10.4         MARKET SHARE ANALYSIS, 2024                 251

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 254

10.5.1      STARS   254

10.5.2      EMERGING LEADERS     254

10.5.3      PERVASIVE PLAYERS      254

10.5.4      PARTICIPANTS 254

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         256

10.5.5.1  Company footprint               256

10.5.5.2  Region footprint   256

10.5.5.3  Product footprint  257

10.5.5.4  Indication footprint              258

10.5.5.5  End-user footprint                258

10.6         COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2024        259

10.6.1      PROGRESSIVE COMPANIES         259

10.6.2      RESPONSIVE COMPANIES            259

10.6.3      DYNAMIC COMPANIES  259

10.6.4      STARTING BLOCKS         259

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 261

10.6.5.1  Detailed list of key startups/SMEs    261

10.6.5.2  Competitive benchmarking of startups/SMEs 261

10.7         COMPANY VALUATION & FINANCIAL METRICS 262

10.7.1      FINANCIAL METRICS      262

10.7.2      COMPANY VALUATION 262

10.8         BRAND/PRODUCT COMPARISON             263

10.9         R&D ASSESSMENT OF KEY PLAYERS        264

10.10       COMPETITIVE SCENARIO             264

10.10.1   PRODUCT LAUNCHES & APPROVALS     264

10.10.2   DEALS  265

10.10.3   OTHER DEVELOPMENTS              266

11            COMPANY PROFILES      267

11.1         KEY PLAYERS     267

11.1.1      JOHNSON & JOHNSON SERVICES, INC.   267

11.1.1.1  Business overview 267

11.1.1.2  Products offered   268

11.1.1.3  Recent developments           271

11.1.1.3.1                Product launches and approvals         271

11.1.1.3.2                Deals      272

11.1.1.4  MnM view              272

11.1.1.4.1                Right to win           272

11.1.1.4.2                Strategic choices   272

11.1.1.4.3                Weaknesses & competitive threats     272

11.1.2      ABBOTT               273

11.1.2.1  Business overview 273

11.1.2.2  Products offered   274

11.1.2.3  Recent developments           275

11.1.2.3.1                Product launches  275

11.1.2.3.2                Deals      276

11.1.2.4  MnM view              276

11.1.2.4.1                Right to win           276

11.1.2.4.2                Strategic choices   276

11.1.2.4.3                Weaknesses & competitive threats     276

11.1.3      MEDTRONIC      277

11.1.3.1  Business overview 277

11.1.3.2  Products offered   278

11.1.3.3  Recent developments           280

11.1.3.3.1                Product approvals 280

11.1.3.3.2                Deals      280

11.1.3.4  MnM view              281

11.1.3.4.1                Right to win           281

11.1.3.4.2                Strategic choices   281

11.1.3.4.3                Weaknesses & competitive threats     281

11.1.4      KONINKLIJKE PHILIPS N.V.          282

11.1.4.1  Business overview 282

11.1.4.2  Products offered   283

11.1.4.3  Recent developments           284

11.1.4.3.1                Deals      284

11.1.4.4  MnM view              284

11.1.4.4.1                Right to win           284

11.1.4.4.2                Strategic choices   284

11.1.4.4.3                Weaknesses & competitive threats     284

11.1.5      GE HEALTHCARE             285

11.1.5.1  Business overview 285

11.1.5.2  Products offered   286

11.1.5.3  Recent developments           287

11.1.5.3.1                Product approvals and enhancements               287

11.1.5.3.2                Deals      287

11.1.5.4  MnM view              288

11.1.5.4.1                Right to win           288

11.1.5.4.2                Strategic choices   288

11.1.5.4.3                Weaknesses & competitive threats     288

11.1.6      BOSTON SCIENTIFIC CORPORATION     289

11.1.6.1  Business overview 289

11.1.6.2  Products offered   290

11.1.6.3  Recent developments           293

11.1.6.3.1                Product approvals 293

11.1.6.3.2                Deals      293

11.1.7      JAPAN LIFELINE CO., LTD.           294

11.1.7.1  Business overview 294

11.1.7.2  Products offered   295

11.1.8      STEREOTAXIS, INC.         297

11.1.8.1  Business overview 297

11.1.8.2  Products offered   298

11.1.8.3  Recent developments           298

11.1.8.3.1                Product approvals 298

11.1.8.3.2                Deals      298

11.1.9      MICROPORT SCIENTIFIC CORPORATION             299

11.1.9.1  Business overview 299

11.1.9.2  Products offered   300

11.1.9.3  Recent developments           301

11.1.9.3.1                Product approvals 301

11.1.9.3.2                Other developments             301

11.1.10   BIOTRONIK        302

11.1.10.1                 Business overview 302

11.1.10.2                 Products offered   302

11.1.10.3                 Recent developments           303

11.1.10.3.1             Expansions             303

11.1.11   TELEFLEX INCORPORATED        304

11.1.11.1                 Business overview 304

11.1.11.2                 Products offered   305

11.1.11.3                 Recent developments           306

11.1.11.3.1             Deals      306

11.1.12   ACUTUS MEDICAL, INC.                307

11.1.12.1                 Business overview 307

11.1.12.2                 Products offered   308

11.1.12.3                 Recent developments           308

11.1.12.3.1             Product approvals 308

11.1.13   MERIT MEDICAL SYSTEMS           309

11.1.13.1                 Business overview 309

11.1.13.2                 Products offered   310

11.1.13.3                 Recent developments           311

11.1.13.3.1             Deals      311

11.1.14   OSYPKA MEDICAL           312

11.1.14.1                 Business overview 312

11.1.14.2                 Products offered   312

11.1.15   COOK    314

11.1.15.1                 Business overview 314

11.1.15.2                 Products offered   314

11.2         OTHER PLAYERS              315

11.2.1      EPMAP-SYSTEM                315

11.2.2      CATHRX LTD.    315

11.2.3      EP SOLUTIONS 316

11.2.4      CATHVISION      316

11.2.5      TZ MEDICAL, INC.            317

11.2.6      APN HEALTH, LLC           318

11.2.7      LEPU MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.                 319

11.2.8      CARDIOFOCUS 319

11.2.9      SCHWARZER CARDIOTEK             320

11.2.10   IMRICOR              320

12            APPENDIX           321

12.1         DISCUSSION GUIDE        321

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                326

12.3         CUSTOMIZATION OPTIONS        328

12.4         RELATED REPORTS         328

12.5         AUTHOR DETAILS           329

LIST OF TABLES

TABLE 1                ELECTROPHYSIOLOGY MARKET: INCLUSIONS & EXCLUSIONS      32

TABLE 2                STANDARD CURRENCY CONVERSION RATES, 2021–2024 (UNIT OF USD)             33

TABLE 3                ELECTROPHYSIOLOGY MARKET: STUDY ASSUMPTIONS  47

TABLE 4                ELECTROPHYSIOLOGY MARKET: RISK ANALYSIS            48

TABLE 5                GLOBAL ANNUAL CARDIAC SURGICAL VOLUMES PER 100,000 POPULATION (2023)          59

TABLE 6                MAJOR FUNDING BY KEY ORGANIZATIONS, 2023–2024              60

TABLE 7                ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES      69

TABLE 8                INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER               71

TABLE 9                KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY SYSTEMS              72

TABLE 10              US FDA: CLASSIFICATION OF MEDICAL DEVICES                 73

TABLE 11              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              73

TABLE 12              CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2024)         74

TABLE 13              JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY                 75

TABLE 14              CHINA: CLASSIFICATION OF MEDICAL DEVICES                 76

TABLE 15              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 78

TABLE 16              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           78

TABLE 17              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 79

TABLE 18              ELECTROPHYSIOLOGY MARKET: CPT CODES                 80

TABLE 19              ELECTROPHYSIOLOGY MARKET: LIST OF KEY PATENTS, 2025  83

TABLE 20              IMPORT DATA FOR HS CODE 901890, BY COUNTRY,

2020−2024 (USD THOUSAND)    84

TABLE 21              EXPORT DATA FOR HS CODE 901890, BY COUNTRY,

2020−2024 (USD THOUSAND)    85

TABLE 22              INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022–2024 (USD THOUSAND)           85

TABLE 23              AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS,

BY REGION, 2022–2024 (USD THOUSAND)             86

TABLE 24              ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026   87

TABLE 25              ELECTROPHYSIOLOGY MARKET: UNMET NEEDS/END-USER EXPECTATIONS          88

TABLE 26              CASE STUDY 1: JOHNSON & JOHNSON TO EXPAND CARTO SUITE FOR LEVERAGING AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING                 92

TABLE 27              CASE STUDY 2: ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY                 92

TABLE 28              CASE STUDY 3: PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT            93

TABLE 29              ELECTROPHYSIOLOGY MARKET: IMPACT OF AI/GEN AI            95

TABLE 30              US ADJUSTED RECIPROCAL TARIFF RATES                 96

TABLE 31              KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ELECTROPHYSIOLOGY PRODUCTS                97

TABLE 32              ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            101

TABLE 33              ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            102

TABLE 34              ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            103

TABLE 35              3D MAPPING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            104

TABLE 36              ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            106

TABLE 37              RADIOFREQUENCY (RF) ABLATION SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            107

TABLE 38              INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            109

TABLE 39              ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 40              REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY COUNTRY,  2023–2030 (USD MILLION)                 112

TABLE 41              ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            113

TABLE 42              ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 43              CRYOABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     115

TABLE 44              RADIOFREQUENCY (RF) ABLATION CATHETERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            117

TABLE 45              COMPARISON BETWEEN RADIOFREQUENCY ABLATION AND MICROWAVE ABLATION (MWA) CATHETERS                 118

TABLE 46              MICROWAVE ABLATION (MWA) CATHETERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            119

TABLE 47              LASER ABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     120

TABLE 48              ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            121

TABLE 49              ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 50              CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               123

TABLE 51              ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               124

TABLE 52              ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               126

TABLE 53              ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            127

TABLE 54              OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            128

TABLE 55              ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)                130

TABLE 56              ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY,

2023–2030 (USD MILLION)            131

TABLE 57              ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY COUNTRY,

2023–2030 (USD MILLION)            133

TABLE 58              ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT), BY COUNTRY, 2023–2030 (USD MILLION)           135

TABLE 59              ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE (WPW) SYNDROME,  BY COUNTRY, 2023–2030 (USD MILLION)       136

TABLE 60              ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 61              ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            140

TABLE 62              ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS,

BY COUNTRY,  2023–2030 (USD MILLION)            141

TABLE 63              ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               142

TABLE 64              ELECTROPHYSIOLOGY MARKET FOR OTHER END USERS, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 65              ELECTROPHYSIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION)            147

TABLE 66              NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            149

TABLE 67              NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            149

TABLE 68              NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,  2023–2030 (USD MILLION)            150

TABLE 69              NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,

BY TYPE, BY VOLUME, 2023–2030 (UNITS)             150

TABLE 70              NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            151

TABLE 71              NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         151

TABLE 72              NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            152

TABLE 73              NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            152

TABLE 74              US: KEY MACROINDICATORS     153

TABLE 75              US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     153

TABLE 76              US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            154

TABLE 77              US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            154

TABLE 78              US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            155

TABLE 79              US: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)                155

TABLE 80              US: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)                156

TABLE 81              CANADA: KEY MACROINDICATORS         157

TABLE 82              CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            157

TABLE 83              CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            158

TABLE 84              CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            158

TABLE 85              CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 159

TABLE 86              CANADA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            159

TABLE 87              CANADA: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            160

TABLE 88              EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 89              EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            161

TABLE 90              EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            162

TABLE 91              EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,  BY TYPE,

BY VOLUME, 2023–2030 (UNITS) 162

TABLE 92              EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            163

TABLE 93              EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 163

TABLE 94              EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            164

TABLE 95              EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            164

TABLE 96              GERMANY: KEY MACROINDICATORS      165

TABLE 97              GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            165

TABLE 98              GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,  2023–2030 (USD MILLION)            166

TABLE 99              GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 166

TABLE 100            GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            167

TABLE 101            GERMANY: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            167

TABLE 102            GERMANY: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            168

TABLE 103            UK: KEY MACROINDICATORS     169

TABLE 104            UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     169

TABLE 105            UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            170

TABLE 106            UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            170

TABLE 107            UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            171

TABLE 108            UK: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)                171

TABLE 109            UK: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)                172

TABLE 110            FRANCE: KEY MACROINDICATORS          172

TABLE 111            FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            173

TABLE 112            FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            173

TABLE 113            FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            174

TABLE 114            FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 174

TABLE 115            FRANCE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            175

TABLE 116            FRANCE: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            175

TABLE 117            ITALY: KEY MACROINDICATORS               176

TABLE 118            ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     176

TABLE 119            ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            177

TABLE 120            ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            177

TABLE 121            ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            178

TABLE 122            ITALY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)                178

TABLE 123            ITALY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)                179

TABLE 124            SPAIN: KEY MACROINDICATORS               179

TABLE 125            SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     180

TABLE 126            SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            180

TABLE 127            SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            181

TABLE 128            SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            181

TABLE 129            SPAIN: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            182

TABLE 130            SPAIN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)                182

TABLE 131            REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            183

TABLE 132            REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,

BY TYPE,  2023–2030 (USD MILLION)      183

TABLE 133            REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            184

TABLE 134            REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         184

TABLE 135            REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            185

TABLE 136            REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            185

TABLE 137            ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 138            ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            188

TABLE 139            ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,  2023–2030 (USD MILLION)            189

TABLE 140            ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,  BY TYPE,

BY VOLUME, 2023–2030 (UNITS) 189

TABLE 141            ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            190

TABLE 142            ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            190

TABLE 143            ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            191

TABLE 144            ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            191

TABLE 145            JAPAN: KEY MACROINDICATORS              192

TABLE 146            JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     192

TABLE 147            JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            193

TABLE 148            JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            193

TABLE 149            JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            194

TABLE 150            JAPAN: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            194

TABLE 151            JAPAN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)     195

TABLE 152            CHINA: KEY MACROINDICATORS             195

TABLE 153            CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     196

TABLE 154            CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            196

TABLE 155            CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 156            CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 157            CHINA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            198

TABLE 158            CHINA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)     198

TABLE 159            INDIA: KEY MACROINDICATORS               199

TABLE 160            INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     199

TABLE 161            INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            200

TABLE 162            INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)          200

TABLE 163            INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)          201

TABLE 164            INDIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            201

TABLE 165            INDIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)                202

TABLE 166            AUSTRALIA: KEY MACROINDICATORS   202

TABLE 167            AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            203

TABLE 168            AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,  2023–2030 (USD MILLION)            203

TABLE 169            AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 204

TABLE 170            AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            204

TABLE 171            AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            205

TABLE 172            AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            205

TABLE 173            SOUTH KOREA: KEY MACROINDICATORS                 206

TABLE 174            SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            206

TABLE 175            SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,  2023–2030 (USD MILLION)            207

TABLE 176            SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            207

TABLE 177            SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            208

TABLE 178            SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            208

TABLE 179            SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            209

TABLE 180            REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            209

TABLE 181            REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         210

TABLE 182            REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         210

TABLE 183            REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            211

TABLE 184            REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            211

TABLE 185            REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            212

TABLE 186            LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            213

TABLE 187            LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)          213

TABLE 188            LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,  2023–2030 (USD MILLION)            214

TABLE 189            LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,  BY TYPE, BY VOLUME, 2023–2030 (UNITS)      214

TABLE 190            LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            215

TABLE 191            LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         215

TABLE 192            LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            216

TABLE 193            LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            216

TABLE 194            BRAZIL: KEY MACROINDICATORS            217

TABLE 195            BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     217

TABLE 196            BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            218

TABLE 197            BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            218

TABLE 198            BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 219

TABLE 199            BRAZIL: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            219

TABLE 200            BRAZIL: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            220

TABLE 201            MEXICO: KEY MACROINDICATORS          220

TABLE 202            MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            221

TABLE 203            MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            221

TABLE 204            MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)          222

TABLE 205            MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 222

TABLE 206            MEXICO: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            223

TABLE 207            MEXICO: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            223

TABLE 208            REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            224

TABLE 209            REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                224

TABLE 210            REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                225

TABLE 211            REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,  BY TYPE, 2023–2030 (USD MILLION)         225

TABLE 212            REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            226

TABLE 213            REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)          226

TABLE 214            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY REGION,

2023–2030 (USD MILLION)          227

TABLE 215            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            228

TABLE 216            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            228

TABLE 217            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,  BY TYPE, BY VOLUME, 2023–2030 (UNITS)      229

TABLE 218            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         229

TABLE 219            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,  BY TYPE, 2023–2030 (USD MILLION)            230

TABLE 220            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            230

TABLE 221            MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            231

TABLE 222            GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            232

TABLE 223            GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            232

TABLE 224            GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            233

TABLE 225            GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,  2023–2030 (USD MILLION)            233

TABLE 226            GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         234

TABLE 227            GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)            234

TABLE 228            GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            235

TABLE 229            KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,  2023–2030 (USD MILLION) 236

TABLE 230            KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,  BY TYPE, 2023–2030 (USD MILLION)                236

TABLE 231            KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET,  BY TYPE, 2023–2030 (USD MILLION)                237

TABLE 232            KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,  BY TYPE, 2023–2030 (USD MILLION)         237

TABLE 233            KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,  2023–2030 (USD MILLION) 238

TABLE 234            KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY END USER,  2023–2030 (USD MILLION) 238

TABLE 235            UAE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     239

TABLE 236            UAE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            240

TABLE 237            UAE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            240

TABLE 238            UAE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            241

TABLE 239            UAE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)                241

TABLE 240            UAE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)                242

TABLE 241            REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            243

TABLE 242            REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET,  BY TYPE, 2023–2030 (USD MILLION)                243

TABLE 243            REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET,  BY TYPE, 2023–2030 (USD MILLION)                244

TABLE 244            REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET,  BY TYPE, 2023–2030 (USD MILLION)         244

TABLE 245            REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION,

2023–2030 (USD MILLION)          245

TABLE 246            REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            245

TABLE 247            REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,  2023–2030 (USD MILLION) 246

TABLE 248            REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                246

TABLE 249            REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                247

TABLE 250            REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                247

TABLE 251            REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 248

TABLE 252            REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER,  2023–2030 (USD MILLION) 248

TABLE 253            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET     249

TABLE 254            ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION 252

TABLE 255            ELECTROPHYSIOLOGY MARKET: REGION FOOTPRINT       256

TABLE 256            ELECTROPHYSIOLOGY MARKET: PRODUCT FOOTPRINT       257

TABLE 257            ELECTROPHYSIOLOGY MARKET: INDICATION FOOTPRINT       258

TABLE 258            ELECTROPHYSIOLOGY MARKET: END-USER FOOTPRINT       258

TABLE 259            ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS  261

TABLE 260            ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION     261

TABLE 261            ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               264

TABLE 262            ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2022–MAY 2025               265

TABLE 263            ELECTROPHYSIOLOGY MARKET: OTHER DEVELOPMENTS,

JANUARY 2022–MAY 2025               266

TABLE 264            JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW   267

TABLE 265            JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED    268

TABLE 266            JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES AND APPROVALS,  JANUARY 2022–MAY 2025        271

TABLE 267            JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–MAY 2025               272

TABLE 268            ABBOTT: COMPANY OVERVIEW                273

TABLE 269            ABBOTT: PRODUCTS OFFERED 274

TABLE 270            ABBOTT: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025              275

TABLE 271            ABBOTT: DEALS, JANUARY 2022–MAY 2025                 276

TABLE 272            MEDTRONIC: COMPANY OVERVIEW       277

TABLE 273            MEDTRONIC: PRODUCTS OFFERED        278

TABLE 274            MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–MAY 2025   280

TABLE 275            MEDTRONIC: DEALS, JANUARY 2022–MAY 2025                 280

TABLE 276            KONINKIJKE PHILIPS N.V.: COMPANY OVERVIEW          282

TABLE 277            KONINKIJKE PHILIPS N.V.: PRODUCTS OFFERED                 283

TABLE 278            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MAY 2025   284

TABLE 279            GE HEALTHCARE: COMPANY OVERVIEW                 285

TABLE 280            GE HEALTHCARE: PRODUCTS OFFERED                 286

TABLE 281            GE HEALTHCARE: PRODUCT APPROVALS AND ENHANCEMENTS,

JANUARY 2022–MAY 2025               287

TABLE 282            GE HEALTHCARE: DEALS, JANUARY 2022–MAY 2025        287

TABLE 283            BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW   289

TABLE 284            BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED    290

TABLE 285            BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,

JANUARY 2022–MAY 2025               293

TABLE 286            BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–MAY 2025               293

TABLE 287            JAPAN LIFELINE CO., LTD.: COMPANY OVERVIEW          294

TABLE 288            JAPAN LIFELINE CO., LTD.: PRODUCTS OFFERED             295

TABLE 289            STEREOTAXIS, INC.: COMPANY OVERVIEW                 297

TABLE 290            STEREOTAXIS, INC.: PRODUCTS OFFERED                 298

TABLE 291            STEREOTAXIS, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025               298

TABLE 292            STEREOTAXIS, INC.: DEALS, JANUARY 2022–MAY 2025        298

TABLE 293            MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW   299

TABLE 294            MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED    300

TABLE 295            MICROPORT SCIENTIFIC CORPORATION: PRODUCT APPROVALS,

JANUARY 2022–MAY 2025               301

TABLE 296            MICROPORT SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS,

JANUARY 2022–MAY 2025               301

TABLE 297            BIOTRONIK: COMPANY OVERVIEW         302

TABLE 298            BIOTRONIK: PRODUCTS OFFERED          302

TABLE 299            BIOTRONIK: EXPANSIONS: JANUARY 2022–MAY 2025        303

TABLE 300            TELEFLEX INCORPORATED: COMPANY OVERVIEW          304

TABLE 301            TELEFLEX INCORPORATED: PRODUCTS OFFERED             305

TABLE 302            TELEFLEX INCORPORATED: DEALS, JANUARY 2022–MAY 2025   306

TABLE 303            ACUTUS MEDICAL, INC.: COMPANY OVERVIEW                 307

TABLE 304            ACUTUS MEDICAL, INC.: PRODUCTS OFFERED                 308

TABLE 305          ACUTUS MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025               308

TABLE 306            MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW          309

TABLE 307            MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED             310

TABLE 308            MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2022–MAY 2025   311

TABLE 309            OSYPKA MEDICAL: COMPANY OVERVIEW                 312

TABLE 310            OSYPKA MEDICAL: PRODUCTS OFFERED                 312

TABLE 311            COOK: COMPANY OVERVIEW    314

TABLE 312            COOK: PRODUCTS OFFERED     314

TABLE 313            EPMAP-SYSTEM: COMPANY OVERVIEW 315

TABLE 314            CATHRX LTD.: COMPANY OVERVIEW     315

TABLE 315            EP SOLUTIONS: COMPANY OVERVIEW  316

TABLE 316            CATHVISION: COMPANY OVERVIEW      316

TABLE 317            TZ MEDICAL, INC.: COMPANY OVERVIEW                 317

TABLE 318            APN HEALTH, LLC: COMPANY OVERVIEW                 318

TABLE 319            LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW       319

TABLE 320            CARDIOFOCUS: COMPANY OVERVIEW  319

TABLE 321            SCHWARZER CARDIOTEK: COMPANY OVERVIEW          320

TABLE 322            IMRICOR: COMPANY OVERVIEW               320

LIST OF FIGURES

FIGURE 1              ELECTROPHYSIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE    31

FIGURE 2              ELECTROPHYSIOLOGY MARKET: YEARS CONSIDERED    33

FIGURE 3              ELECTROPHYSIOLOGY MARKET: RESEARCH DESIGN                35

FIGURE 4              ELECTROPHYSIOLOGY MARKET: KEY DATA FROM SECONDARY SOURCES    36

FIGURE 5              ELECTROPHYSIOLOGY MARKET: KEY PRIMARY SOURCES (SUPPLY AND DEMAND SIDES)             37

FIGURE 6              ELECTROPHYSIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES            38

FIGURE 7              BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION  38

FIGURE 8              BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION            39

FIGURE 9              ELECTROPHYSIOLOGY MARKET: INSIGHTS FROM INDUSTRY EXPERTS          39

FIGURE 10            ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (REVENUE SHARE ANALYSIS)                 40

FIGURE 11            MARKET REVENUE ESTIMATION OF MEDTRONIC (2024)         41

FIGURE 12            ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE ANALYSIS            41

FIGURE 13            ELECTROPHYSIOLOGY MARKET: BOTTOM-UP APPROACH         42

FIGURE 14            ELECTROPHYSIOLOGY MARKET: TOP-DOWN APPROACH         42

FIGURE 15            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ELECTROPHYSIOLOGY MARKET               44

FIGURE 16            ELECTROPHYSIOLOGY MARKET: CAGR PROJECTIONS

(SUPPLY-SIDE ANALYSIS), 2024  45

FIGURE 17            ELECTROPHYSIOLOGY MARKET: DATA TRIANGULATION METHODOLOGY         46

FIGURE 18            ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)      49

FIGURE 19            ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)          50

FIGURE 20            ELECTROPHYSIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      50

FIGURE 21            ELECTROPHYSIOLOGY MARKET: REGIONAL SNAPSHOT          51

FIGURE 22            RISING INCIDENCE OF CARDIOVASCULAR DISORDERS TO DRIVE MARKET                 52

FIGURE 23            US AND ELECTROPHYSIOLOGY ABLATION CATHETERS ACCOUNTED FOR LARGEST NORTH AMERICAN MARKET SHARE IN 2024 53

FIGURE 24            ASIA PACIFIC TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD       53

FIGURE 25            CHINA AND INDIA TO ACCOUNT FOR HIGHEST GROWTH RATES

FROM 2025 TO 2030          54

FIGURE 26            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD            54

FIGURE 27            ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          55

FIGURE 28            ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 69

FIGURE 29            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER               71

FIGURE 30            KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY END USERS         72

FIGURE 31            TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015–JUNE 2025)      82

FIGURE 32            TOP APPLICANT COUNTRIES/REGIONS FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015–JUNE 2025)                 83

FIGURE 33            ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS            89

FIGURE 34            ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS              91

FIGURE 35            ELECTROPHYSIOLOGY MARKET: ECOSYSTEM ANALYSIS            91

FIGURE 36            ADJACENT MARKETS TO ELECTROPHYSIOLOGY MARKET               94

FIGURE 37            ELECTROPHYSIOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES                 94

FIGURE 38            ELECTROPHYSIOLOGY MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024         95

FIGURE 39            ELECTROPHYSIOLOGY MARKET: GEOGRAPHIC SNAPSHOT          146

FIGURE 40            NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT       148

FIGURE 41            ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT          187

FIGURE 42            REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2020−2024)     251

FIGURE 43            MARKET SHARE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY

MARKET (2024) 252

FIGURE 44            ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       255

FIGURE 45            ELECTROPHYSIOLOGY MARKET: COMPANY FOOTPRINT       256

FIGURE 46            ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 260

FIGURE 47            EV/EBITDA OF KEY VENDORS   262

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS      262

FIGURE 49            ELECTROPHYSIOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     263

FIGURE 50            ELECTROPHYSIOLOGY MARKET: R&D ASSESSMENT OF KEY PLAYERS,

2022–2024              264

FIGURE 51            JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT   268

FIGURE 52            ABBOTT: COMPANY SNAPSHOT                274

FIGURE 53            MEDTRONIC: COMPANY SNAPSHOT      278

FIGURE 54            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT          283

FIGURE 55            GE HEALTHCARE: COMPANY SNAPSHOT                 286

FIGURE 56            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT   290

FIGURE 57            JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT          295

FIGURE 58            STEREOTAXIS, INC.: COMPANY SNAPSHOT                 297

FIGURE 59            MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT   300

FIGURE 60            TELEFLEX INCORPORATED: COMPANY SNAPSHOT          305

FIGURE 61            ACUTUS MEDICAL, INC.: COMPANY SNAPSHOT                 307

FIGURE 62            MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT          310

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧